SUN Yan-ni, WANG Guo-jie, ZHEN Xin-an, LIU Zhan-feng, Harley David, Hall Gillian, Vally Hassan, Sleigh Adrian.. The economic status and treatment cost of MDR-TB patients compared to nonMDR-TB patients in Henan province[J]. Chinese Journal of Antituberculosis, 2012, 34(12): 773-779.
[1]Jackson S, Sleigh AC, Wang GJ, et al. Poverty and the economic effects of TB in rural China. Int J Tuberc Lung Dis, 2006, 10(10):1104-1110.[2]Xu B, Dong HJ, Zhao Q, et al. DOTS in China-removing barriers or moving barriers? Health Policy Plan, 2006,21(5):365-372.[3]Spence DP, Hotchkiss J, Williams CS, et al. Tuberculosis and poverty. BMJ, 1993, 307:759-761.[4]赵大海,徐飚.结核病与贫穷. 中国防痨杂志,2004,26 (3):177-179.[5]王宇. 全国第五次结核病流行病学抽样调查资料汇编.北京:军事医学科学出版社,2012:52-60.[6]World Health Organization. Guidelines for the programmatic management of drugresistant tuberculosis. Geneva: World Health Organization, 2008.[7]杜长梅,王国斌,徐吉英,等.河南省第二轮结核病耐药监测及耐药趋势的研究.中国防痨杂志,2006,4(2):95-99.[8]Rajbhandary SS, Marks SM,Bock NN. Costs of patients hospitalized for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis, 2004, 8 (8):1012-1016.[9]王黎霞.中国耐多药结核病的控制亟待加强. 中华结核和呼吸杂志, 2009, 32 (8):561-563.[10]申振元,陈伟, 马桂芳,等. 河南省2009年肺结核疫情特征流行病学分析.现代预防医学, 2012,39(4):993-994.[11]Wilson LG. The historical decline of tuberculosis in Europe and America: its causes and significance. J Hist Med Allied Sci,1990,45(3):366-396.[12]Schoeman J, Westaway M, Neethling A. The relationship between socioeconomic factors and pulmonary tuberculosis. Int J Epidemiol,1991,20(2):435-440.[13]邓斌,何庆伟, 余锦香,等. 初治肺结核治愈后复发危险因素 COX 比例风险模型研究. 国际医药卫生导报, 2005,(17): 28-30.[14]王纪祥.安徽省结核病控制项目1997年病人化疗情况调查. 疾病控制杂志, 1999, 3(3):189-191.[15]陈兆辉. 世行贷款方案治疗肺结核失败227 例原因分析. 临床肺科杂志, 2001, 6(4):16-18.[16]World Health Organization.Global tuberculosis control: WHO report 2010. Geneva:World Health Organization,2011.[17]Benatar SR,Upshur R.Tuberculosis and poverty: what could (and should) be done. Int J Tuberc Lung Dis,2010,14(10):1215-1221.